Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives

Clin Exp Med. 2023 Nov;23(7):3321-3338. doi: 10.1007/s10238-023-01128-8. Epub 2023 Jul 8.

Abstract

Clinical observations suggest that the prevalence of autoimmune diseases is changing over time. Both autoimmune liver diseases and multiple sclerosis have shown a significant increase in the last decades. Although the coexistence of autoimmune diseases within individuals and families is a common phenomenon, the extent to which liver disease and multiple sclerosis co-occur is not clear. Case reports and few studies have reported the possible coexistence of multiple sclerosis with thyroid diseases, inflammatory bowel disease, psoriasis, and rheumatoid arthritis. It is unknown whether there is a definite association between multiple sclerosis and autoimmune liver diseases. We reviewed the literature to summarize the available studies on the association between different autoimmune liver diseases (autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis) and treated or untreated multiple sclerosis.

Keywords: Autoimmune hepatitis; Liver; Multiple sclerosis; Primary biliary cholangitis.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases* / complications
  • Autoimmune Diseases* / epidemiology
  • Hepatitis, Autoimmune* / complications
  • Hepatitis, Autoimmune* / epidemiology
  • Humans
  • Inflammatory Bowel Diseases*
  • Liver Cirrhosis, Biliary*
  • Liver Diseases* / complications
  • Liver Diseases* / epidemiology
  • Multiple Sclerosis* / complications
  • Multiple Sclerosis* / epidemiology
  • Psoriasis*